257 related articles for article (PubMed ID: 14961571)
1. -160C/A polymorphism in the E-cadherin gene promoter and risk of hereditary, familial and sporadic prostate cancer.
Jonsson BA; Adami HO; Hägglund M; Bergh A; Göransson I; Stattin P; Wiklund F; Grönberg H
Int J Cancer; 2004 Apr; 109(3):348-52. PubMed ID: 14961571
[TBL] [Abstract][Full Text] [Related]
2. Significance of an E-cadherin gene promoter polymorphism for risk and disease severity of prostate cancer in a Japanese population.
Goto T; Nakano M; Ito S; Ehara H; Yamamoto N; Deguchi T
Urology; 2007 Jul; 70(1):127-30. PubMed ID: 17656222
[TBL] [Abstract][Full Text] [Related]
3. Single-nucleotide polymorphism in the E-cadherin gene promoter modifies the risk of prostate cancer.
Verhage BA; van Houwelingen K; Ruijter TE; Kiemeney LA; Schalken JA
Int J Cancer; 2002 Aug; 100(6):683-5. PubMed ID: 12209606
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms in CDH1 and Exo1 genes elevate the prostate cancer risk in Bangladeshi population.
Imtiaz H; Afroz S; Hossain MA; Bellah SF; Rahman MM; Kadir MS; Sultana R; Mazid MA; Rahman MM
Tumour Biol; 2019 Mar; 41(3):1010428319830837. PubMed ID: 30880589
[TBL] [Abstract][Full Text] [Related]
5. H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer.
Lindmark F; Zheng SL; Wiklund F; Bensen J; Bälter KA; Chang B; Hedelin M; Clark J; Stattin P; Meyers DA; Adami HO; Isaacs W; Grönberg H; Xu J
J Natl Cancer Inst; 2004 Aug; 96(16):1248-54. PubMed ID: 15316060
[TBL] [Abstract][Full Text] [Related]
6. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer.
Humar B; Graziano F; Cascinu S; Catalano V; Ruzzo AM; Magnani M; Toro T; Burchill T; Futschik ME; Merriman T; Guilford P
Oncogene; 2002 Nov; 21(53):8192-5. PubMed ID: 12444556
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin gene polymorphisms and haplotype associated with the occurrence of epithelial ovarian cancer in Chinese.
Li Y; Liang J; Kang S; Dong Z; Wang N; Xing H; Zhou R; Li X; Zhao X
Gynecol Oncol; 2008 Feb; 108(2):409-14. PubMed ID: 18035404
[TBL] [Abstract][Full Text] [Related]
8. The MTHFR 677C --> T polymorphism and risk of prostate cancer: results from the CAPS study.
Johansson M; Van Guelpen B; Hultdin J; Wiklund F; Adami HO; Bälter K; Grönberg H; Stattin P
Cancer Causes Control; 2007 Dec; 18(10):1169-74. PubMed ID: 17846906
[TBL] [Abstract][Full Text] [Related]
9. Promoter methylation and polymorphism of E-cadherin gene may confer a risk to prostate cancer: a meta-analysis based on 22 studies.
Chang Z; Zhou H; Liu Y
Tumour Biol; 2014 Oct; 35(10):10503-13. PubMed ID: 25056535
[TBL] [Abstract][Full Text] [Related]
10. Lack of evidence for the association of E-cadherin gene polymorphism with increased risk or progression of prostate cancer.
Tsukino H; Kuroda Y; Imai H; Nakao H; Qiu D; Komiya Y; Inatomi H; Hamasaki T; Kohshi K; Osada Y; Katoh T
Urol Int; 2004; 72(3):203-7. PubMed ID: 15084762
[TBL] [Abstract][Full Text] [Related]
11. CDH1 -160C>A gene polymorphism is an ethnicity-dependent risk factor for gastric cancer.
Chen B; Zhou Y; Yang P; Liu L; Qin XP; Wu XT
Cytokine; 2011 Aug; 55(2):266-73. PubMed ID: 21570316
[TBL] [Abstract][Full Text] [Related]
12. [Association of three single nucleotide polymorphisms of the E-cadherin gene with susceptibility to epithelial ovarian carcinoma].
Liang J; Li Y; Wang N
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):183-6. PubMed ID: 18393242
[TBL] [Abstract][Full Text] [Related]
13. Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer.
Porter TR; Richards FM; Houlston RS; Evans DG; Jankowski JA; Macdonald F; Norbury G; Payne SJ; Fisher SA; Tomlinson I; Maher ER
Oncogene; 2002 Mar; 21(12):1928-33. PubMed ID: 11896626
[TBL] [Abstract][Full Text] [Related]
14. Single nucleotide polymorphisms in the promoter region of the E-cadherin gene in gastric cancer: case-control study in a young Mexican population.
Medina-Franco H; Ramos-De la Medina A; Vizcaino G; Medina-Franco JL
Ann Surg Oncol; 2007 Aug; 14(8):2246-9. PubMed ID: 17549573
[TBL] [Abstract][Full Text] [Related]
15. A single nucleotide polymorphism in the E-cadherin gene promoter -160 C/A is associated with risk of nasopharyngeal cancer.
Ben Nasr H; Hamrita B; Batbout M; Gabbouj S; Bouaouina N; Chouchane L; Chahed K
Clin Chim Acta; 2010 Sep; 411(17-18):1253-7. PubMed ID: 20462505
[TBL] [Abstract][Full Text] [Related]
16. CDH1 polymorphisms and haplotypes in sporadic diffuse and intestinal gastric cancer: a case-control study based on direct sequencing analysis.
Chu CM; Chen CJ; Chan DC; Wu HS; Liu YC; Shen CY; Chang TM; Yu JC; Harn HJ; Yu CP; Yang MH
World J Surg Oncol; 2014 Mar; 12():80. PubMed ID: 24684952
[TBL] [Abstract][Full Text] [Related]
17. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
[TBL] [Abstract][Full Text] [Related]
18. PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility.
Lai J; Kedda MA; Hinze K; Smith RL; Yaxley J; Spurdle AB; Morris CP; Harris J; Clements JA
Carcinogenesis; 2007 May; 28(5):1032-9. PubMed ID: 17151093
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in the COX-2 gene and the association with prostate cancer risk.
Shahedi K; Lindström S; Zheng SL; Wiklund F; Adolfsson J; Sun J; Augustsson-Bälter K; Chang BL; Adami HO; Liu W; Grönberg H; Xu J
Int J Cancer; 2006 Aug; 119(3):668-72. PubMed ID: 16506214
[TBL] [Abstract][Full Text] [Related]
20. CDH1 C-160A promoter polymorphism and gastric cancer risk.
Corso G; Berardi A; Marrelli D; Pedrazzani C; Garosi L; Pinto E; Roviello F
Eur J Cancer Prev; 2009 Feb; 18(1):46-9. PubMed ID: 19077564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
